Novel Antidepressant Agomelatin Targets Melatonin and Serotonin Receptors: Presented at CPA

News -Docguide "The soon-to-be-available antidepressant agomelatin offers excellent efficacy with great tolerability and sleep improvements to boot. Raymond W. Lam, MD, Professor and Head of Clinical Neuroscience, Department of Psychiatry, Faculty of Medicine, University of British Columbia, Vancouver, Canada, presented the latest findings on this agent here at the 57th Annual Conference of the Canadian Psychiatric Association "